Home » Topics » Disease categories and therapies » Immune

Immune
RSS

First potent and selective CB2 receptor antagonist developed at Sanofi

Feb. 24, 1998

Pneumovax does not prevent pneumonia in middle-aged and elderly immunocompetent patients

Feb. 19, 1998

Cytokine-inducing profile of imiquimod and two analogues characterized in monkeys

Feb. 19, 1998

Zenapax uveitis and transplant trial data reported

Feb. 19, 1998

FDA issues positive action letter for SangStat's ciclosporin; European filing announced

Feb. 19, 1998

First launch for Zenapax

Feb. 17, 1998

Immunosuppressive profile of activity of PS-64 extract

Feb. 17, 1998

Novel immunosuppressive extract magnifies the efficacy of ciclosporin in vitro

Feb. 17, 1998

New formulation of FK-506 demonstrates superior efficacy

Feb. 17, 1998

Phase III European trial results reinforce potential value of anti-LFA-1 MAb

Feb. 17, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...